The emerging treatment of tirzepatide peptide represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide277721.oblogation.com/40876216/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment